Oral Abstract: Insights in immunology and immunosuppression
Sunday September 21, 2025 from 09:15 to 10:45
MOA 4
Moderators
Lectures
-
412.1 Association of intraindividual tacrolimus variability and concentration-to-dose ratio with allograft rejection in pediatric kidney transplant recipientsDr. Maral Baghai Arassi, Germany
-
412.2 Evaluating the Risk and Benefit of Once Daily Mycophenolate Acid in Pediatric Kidney Transplant RecipientsMrs. Lynn Maestretti, United States
-
412.3 Immune Monitoring by Torque-Teno Virus Load in Addition to Virus-Specific T Cells After Pediatric Kidney TransplantationMr. David Nehl, Germany
-
412.4 Outcomes after basiliximab, thymoglobulin, or alemtuzumab induction for pediatric kidney transplant: A single center studyDr. Katherine D Westreich, United States
-
412.5 Insights into the Interplay between Senescent Cells and Immune Cells in the Kidney MicroenvironmentMr. Martin Jaros, Germany
-
412.6 Sex differences in endothelial cell senescence are independent of gonadal-hormonesMs. Anna Quarder, Germany
-
412.7 Evaluating Feasibility and Clinical Relevance of Pharmacogenomic Testing using Whole Genome Sequencing in Pediatric Kidney TransplantationDr. Sandra Amaral, United States
-
412.8 Pharmacogenetics in pediatric kidney transplant: Leveraging CYP3A5-guided therapy for improved patient outcomesMs. Sierra Scodellaro, Canada
-
412.9 CD4 counts exhibit poor recovery in pediatric transplant patients with single ventricle physiologyDr. Brian Madden, United States